Do you want to read an article? Please log in or register.
Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
Related content
Long-acting muscarinic antagonist and long-acting β2-agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery
Mol Clin Oncol.
Makino T, Otsuka H, Hata Y, Koezuka S, Azuma Y, Isobe K, Sugino K, Ebihara S, Homma S, Iyoda A
doi: 10.3892/mco.2018.1595.
COMMENTED
Asthma
Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β2-agonists for adults with asthma
Respir Med.
Buhl R, FitzGerald JM, Busse WW
doi: 10.1016/j.rmed.2018.08.014.
COPD
Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD
Pulm Pharmacol Ther.
Mandal J, Roth M, Papakonstantinou E, Sun Q, Costa L, Boeck L, Scherr A, Rakic J, Louis R, Milenkovic B, Boersma W, Kostikas K, Blasi F, Aerts J, Rohde G, Lacoma A, Torres A, Welte T, Tamm M, Stolz D
doi: 10.1016/j.pupt.2017.10.011.
Asthma
The pediatric asthma yardstick: practical recommendations for a sustained step-up in asthma therapy for children with inadequately controlled asthma
Ann Allergy Asthma Immunol.
Chipps BE, Bacharier LB, Farrar JR, Jackson DJ, Murphy KR, Phipatanakul W, Szefler SJ, Teague WG, Zeiger RS
doi: 10.1016/j.anai.2018.04.002.
RECOMMENDED
COPD
Triple therapy versus single and dual long-acting bronchodilator therapy in chronic obstructive pulmonary disease: a systematic review and meta-analysis
Eur Respir J.
Cazzola M, Rogliani P, Calzetta L, Matera MG
doi: 10.1183/13993003.
RECOMMENDED
AsthmaCOPDEmphysemaTachypnea
Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Rogliani P, Ritondo BL, Puxeddu E, Cazzola M, Calzetta L
doi: 10.1016/j.rmed.2021.106639
COPD
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial
Lancet.
Vestbo J, Papi A, Corradi M, Blazhko V, Montagna I, Francisco C, Cohuet G, Vezzoli S, Scuri M, Singh D
doi: 10.1016/S0140-6736
RECOMMENDED
COPD
Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis
Cochrane Database Syst Rev.
Oba Y, Keeney E, Ghatehorde N, Dias S
doi: 10.1002/14651858.
COMMENTED
Consequences of long-term OCS therapy and its side effects in severe asthma in adults - A focused review of the impact data in the literature
Eur Respir J.
Volmer T, Effenberger T, Trautner C, Buhl R
doi: 10.1183/